362 related articles for article (PubMed ID: 38741193)
1. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases.
Nguyen-Thi PT; Ho TT; Nguyen TT; Vo GV
Curr Drug Deliv; 2024; 21(7):917-931. PubMed ID: 37424345
[TBL] [Abstract][Full Text] [Related]
2. Brain Targeting Nanomedicines: Pitfalls and Promise.
Kakinen A; Jiang Y; Davis TP; Teesalu T; Saarma M
Int J Nanomedicine; 2024; 19():4857-4875. PubMed ID: 38828195
[TBL] [Abstract][Full Text] [Related]
3. Exosomes: The endogenous nanomaterials packed with potential for diagnosis and treatment of neurologic disorders.
Tang X; He Y; Liu J; Xu J; Peng Q
Colloids Surf B Biointerfaces; 2024 Jul; 239():113938. PubMed ID: 38718474
[TBL] [Abstract][Full Text] [Related]
4. Novel Biomaterials Based Strategies for Neurodegeneration: Recent Advancements and Future Prospects.
Singh D; Nagdev S
Curr Drug Deliv; 2024; 21(8):1037-1049. PubMed ID: 38310440
[TBL] [Abstract][Full Text] [Related]
5.
Tanudji J; Kasai H; Okada M; Ogawa T; Aspera SM; Nakanishi H
Phys Chem Chem Phys; 2024 May; 26(17):12915-12927. PubMed ID: 38629229
[TBL] [Abstract][Full Text] [Related]
6. Reconsidering red blood cells as the diagnostic potential for neurodegenerative disorders.
Yadav S; Deepika ; Moar K; Kumar A; Khola N; Pant A; Kakde GS; Maurya PK
Biol Cell; 2024 May; ():e2400019. PubMed ID: 38822416
[TBL] [Abstract][Full Text] [Related]
7. Bio-Nano Toolbox for Precision Alzheimer's Disease Gene Therapy.
Liu Y; Xia X; Zheng M; Shi B
Adv Mater; 2024 May; ():e2314354. PubMed ID: 38778446
[TBL] [Abstract][Full Text] [Related]
8. The why and how of the SynNerGe criteria of Parkinson´s disease.
Höglinger GU; Lang AE
J Neural Transm (Vienna); 2024 Jun; ():. PubMed ID: 38916622
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose Radiation Therapy for Neurological Disorders: A Double-Edged Sword.
Weerasinghe-Mudiyanselage PDE; Kim JS; Kang S; Lee YS; Son Y; Lee HJ; Moon C
Discov Med; 2024 May; 36(184):898-912. PubMed ID: 38798250
[TBL] [Abstract][Full Text] [Related]
10. Cytoskeleton-modulating nanomaterials and their therapeutic potentials.
Park J; Wu Y; Suk Kim J; Byun J; Lee J; Oh YK
Adv Drug Deliv Rev; 2024 Jun; 211():115362. PubMed ID: 38906478
[TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
[TBL] [Abstract][Full Text] [Related]
12. Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases.
Sengupta U; Kayed R
Prog Neurobiol; 2022 Jul; 214():102270. PubMed ID: 35447272
[TBL] [Abstract][Full Text] [Related]
13. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders.
Mollenhauer B; Parnetti L; Rektorova I; Kramberger MG; Pikkarainen M; Schulz-Schaeffer WJ; Aarsland D; Svenningsson P; Farotti L; Verbeek MM; Schlossmacher MG
J Neurochem; 2016 Oct; 139 Suppl 1():290-317. PubMed ID: 26452984
[TBL] [Abstract][Full Text] [Related]
14. Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases.
Tapia-Arellano A; Cabrera P; Cortés-Adasme E; Riveros A; Hassan N; Kogan MJ
J Nanobiotechnology; 2024 May; 22(1):248. PubMed ID: 38741193
[TBL] [Abstract][Full Text] [Related]
15. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for neurodegenerative diseases.
Hansson O
Nat Med; 2021 Jun; 27(6):954-963. PubMed ID: 34083813
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
